• Home
  • Ricardo Gaminha Pacheco
Ricardo Gaminha Pacheco

Ricardo Gaminha Pacheco
BSG Pharmaceuticals

MD | MBA | MPH
Chief Strategy Officer & Business Development Head at BSG Pharmaceuticals - looking for R&D Partnerships/Collaborations

About

6
Publications
149
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
7
Citations
Introduction
Ricardo Gaminha Pacheco currently works at BSG Pharmaceticals as Chief Strategy Officer & Business Development Head. Ricardo is responsible in setting the future strategy of the company, seeking and managing external strategic partnerships & collaborations across R&D, Manufacturing, Medical Affairs and Commercial .
Additional affiliations
February 2020 - May 2021
Roche
Position
  • Managing Director
Description
  • Responsible for leading the implementation of the Clinical Development program and develop Medical Affairs pre-launch plan of the Oncology Business Unit Strategy for Gynecologic Cancers. Focus on Strategy & Scenario Planning for Ovarian, Endometrial and Cervical Cancer, impactful Growth Initiatives, Data & Digital and Portfolio Optimization. Providing Financial and Strategic Insights for accurate Forecasting, Business Growth & Profitability
May 2019 - February 2020
AstraZeneca
Position
  • Women's Cancer Oncology Franchise Head
Description
  • Responsible for leading the UK Women’s Cancer Oncology Franchise – Breast & Gynaecologic Cancer : Lead the Women’s Cancer Franchise and plan, coordinate and control all Medical, Clinical and Scientific expertise related issues related with Breast Cancer optimized Portfolio and new strategic focus – Antibody Drug Conjugates and Gynaecologic Cancer with strategic focus on different indications in Ovarian Cancer.
July 2017 - May 2019
Novartis
Position
  • Managing Director
Description
  • Plan, coordinate and control all Medical, Clinical and Scientific expertise related issues, by establishing partnerships with internal and external stakeholders, managing the Medical Team, driving strategy and global strategic alignment, planning and managing studies and publications, manage medical budget and strategy, in order to ensure a high level of Medical Affairs performance and Leadership
Education
September 2020 - February 2021
Universidade NOVA de Lisboa
Field of study
  • Human Genetics & Genomic Medicine
September 2020 - September 2021
London School of Hygiene and Tropical Medicine
Field of study
  • Public Health
September 2018 - November 2020
Nova School of Business and Economics
Field of study
  • Business Administration

Publications

Publications (6)
Article
Full-text available
Background Patients’ involvement in the health technology assessment (HTA) decision-making process is important for transparency, legitimacy and fairness. The study objectives were to understand breast cancer patients’ perspectives when choosing their treatment, highlight treatment characteristics valued as most important by patients and gain infor...
Article
Full-text available
Fingolimod, a structural analogue of sphingosine, is the first oral treatment available for multiple sclerosis. The presence of sphingosine-1-phosphate receptors in the sinus and atrioventricular nodes, myocardial cells, endothelial cells and arterial smooth muscle cells is responsible for fingolimod's cardiovascular effects. We provide a comprehen...

Network

Cited By